MEI Pharma, Inc. financial data

Symbol
MEIP on Nasdaq
Industry
Pharmaceutical Preparations
Location
11455 El Camino Real, Suite 250, San Diego, CA
State of incorporation
DE
Fiscal year end
June 30
Former names
MARSHALL EDWARDS INC (to 6/6/2012)
Latest financial report
10-Q - Q4 2024 - Feb 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 658 % +4.2%
Debt-to-equity 25.8 % -78.1%
Return On Equity -117 % -394%
Return On Assets -92.8 % -608%
Operating Margin 22.3 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.66M shares 0%
Common Stock, Shares, Outstanding 6.66M shares 0%
Entity Public Float 28.7M USD -9.75%
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 6.66M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 6.66M shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD -100%
Research and Development Expense 12.6M USD -49.6%
General and Administrative Expense 17.1M USD -46.1%
Costs and Expenses 40.6M USD -28.5%
Operating Income (Loss) -40.6M USD -356%
Nonoperating Income (Expense) 2.4M USD -39.6%
Net Income (Loss) Attributable to Parent -38.2M USD -293%
Earnings Per Share, Basic -5.73 USD/shares -293%
Earnings Per Share, Diluted -5.73 USD/shares -293%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 23.7M USD +359%
Cash, Cash Equivalents, and Short-term Investments 23.7M USD -60.2%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD
Assets, Current 24.4M USD -63.1%
Property, Plant and Equipment, Net 0 USD -100%
Operating Lease, Right-of-Use Asset 0 USD -100%
Assets 24.4M USD -69%
Accounts Payable, Current 596K USD -56.7%
Employee-related Liabilities, Current 1.48M USD -34%
Accrued Liabilities, Current 1.69M USD -70%
Liabilities, Current 2.29M USD -71.5%
Operating Lease, Liability, Noncurrent 0 USD -100%
Liabilities 2.29M USD -88%
Retained Earnings (Accumulated Deficit) -399M USD -10.6%
Stockholders' Equity Attributable to Parent 22.1M USD -62.9%
Liabilities and Equity 24.4M USD -69%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -11.5M USD +38.1%
Net Cash Provided by (Used in) Financing Activities 0 USD
Net Cash Provided by (Used in) Investing Activities 14.7M USD +196%
Common Stock, Shares Authorized 226M shares 0%
Common Stock, Shares, Issued 6.66M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares
Deferred Tax Assets, Valuation Allowance 69.9M USD -8.24%
Deferred Tax Assets, Gross 69.9M USD -8.24%
Operating Lease, Liability 0 USD -100%
Depreciation 86K USD -11.3%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 14.6M USD -13.7%
Property, Plant and Equipment, Gross 7K USD -99.7%
Operating Lease, Liability, Current 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.48M USD +29.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.91M USD -18.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.96M USD -24%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.55M USD +2.99%
Deferred Tax Assets, Operating Loss Carryforwards 45.7M USD +32.5%
Preferred Stock, Shares Issued 100K shares
Preferred Stock, Shares Authorized 100K shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.72M USD +6.43%
Operating Lease, Payments 12.4M USD +441%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 368K USD +323%
Operating Leases, Future Minimum Payments Due 0 USD
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%